Lupus Clinical Trials in Phoenix

Showing 41-60 of 100 trials

Effects of Health and Wellness App on Employee Productivity

NCT05120310

The purpose of this study is to test the effects of using the Calm app + coaching concierge (one 20-min session) and/or Calm Coaching for sleep program on sleep, mental health, and work productivity outcomes in employees. Employees (N=5,000) will be randomized into one of two groups for 8-weeks.

Sleep DisturbanceMental Health Wellness 1

Arizona State University1,029 participantsStarted Aug 2021

Phoenix, Arizona, United States

COMPLETEDPHASE2< 1 mile

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

NCT03978520

The main objective of this study was to evaluate the safety and efficacy of elsubrutinib, upadacitinib (UPA), and ABBV-599 (elsubrutinib/upadacitinib) High Dose and Low Dose combinations vs placebo for the treatment of signs and symptoms of Systemic Lupus Erythematosus (SLE) in participants with moderately to severely active SLE and to define doses for further development.

Systemic Lupus Erythematosus (SLE)

AbbVie341 participantsStarted Jul 2019

Mesa, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +157 more locations

Effects of Health and Wellness App on Employee Productivity

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Lupus Trials in Other Cities

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

A Phase II Study of M2951 in SLE

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

Post Approval Study of the remedē System

Rituximab and Belimumab for Lupus Nephritis

Nelfinavir in Systemic Lupus Erythematosus

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

Other Conditions in Phoenix